NasdaqCM - Nasdaq Real Time Price USD

INVO Bioscience, Inc. (INVO)

0.9201 -0.0089 (-0.96%)
As of 11:49 AM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS -0.23-0.23----

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----11
Avg. Estimate ----8.44M20.97M
Low Estimate ----8.44M20.97M
High Estimate ----8.44M20.97M
Year Ago Sales ------8.44M
Sales Growth (year/est) ------148.50%

Earnings History

CURRENCY IN USD 3/31/2022 6/30/2022 9/30/2022 12/31/2022
EPS Est. -0.25-0.24-0.13-0.19
EPS Actual -0.23-0.23-0.21-0.23
Difference 0.020.01-0.08-0.04
Surprise % 8.00%4.20%-61.50%-21.10%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 00-0.20
30 Days Ago 00-0.20
60 Days Ago 00-0.20
90 Days Ago 00-0.20

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD INVOIndustrySectorS&P 500
Current Qtr. ------6.60%
Next Qtr. ------11.10%
Current Year ------4.50%
Next Year ------12.50%
Next 5 Years (per annum) ------11.03%
Past 5 Years (per annum) --------

Research Analysis

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Related Tickers